MARIA BASANEZ: Open Payments
NPI 1972109155 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,793 in 106 payments from 13 companies in 2025. Trend: 2023 $2,325 · 2024 $2,455 · 2025 $2,793
Food & beverage: $2,793
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $418 |
| Teva Pharmaceuticals USA, Inc. | 13 | $415 |
| Janssen Pharmaceuticals, Inc | 17 | $400 |
| Axsome Therapeutics, Inc. | 8 | $313 |
| Lundbeck LLC | 10 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $228 |
| Vanda Pharmaceuticals Inc. | 7 | $222 |
| Alkermes, Inc. | 7 | $168 |
| Otsuka America Pharmaceutical, Inc. | 10 | $152 |
| ABBVIE INC. | 5 | $106 |
Products named: COBENFY, UZEDY, REXULTI, Auvelity, INVEGA SUSTENNA, CAPLYTA, HETLIOZ, ARISTADA.
Industry payments across FL — which companies pay providers there.
